Federal Register Notice: FDA’s Peripheral and Central Nervous System Drugs Advisory Committee will meet 12/6, from 8 a.m. to 5 p.m. at the Sheraton College Park Hotel, The Ballroom, 4095 Powder Mill Rd., Beltsville, MD. The committee will discuss Prestwick Pharmaceuticals’ NDA for tetrabenazine for the proposed indication to treat chorea associated with Huntington's disease. Contact Darrell Lyons, (301) 827-7001. To view this notice, click here.
